18F-FDG PET/CT versus anatomic imaging for evaluating disease extent and clinical trial eligibility in Erdheim-Chester disease: results from 50 patients in a registry study is a research paper published in European Journal of Nuclear Medicine and Molecular Imaging (2020). On theSindex it has a DataRank of 1.2. It has been cited 26 times, with 22 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.494
From this paper's citation signal
Citation Network Contribution
0.660
From 15 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 22 citers.
NIH Cancer Center Support Grant
Grant: NIH P30 CA008748
NCI NIH HHS
Grant: P30 CA008748
Erdheim-Chester Disease Global Alliance
Frame Family Fund
Joy Family West Foundation
FWCI
1.13
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords